Among patients receiving treatment for glioblastoma, PPI use is associated with worse progression-free and overall survival, a recent meta-analysis shows.

Systemic therapy for sarcoidosis is reserved for organ-threatening disease, and laryngeal involvement necessitates treatment ...

Bone loss can start before 50 Here is why an early bone density test might be the smartest step to safeguard your future ...

J&J's phase IIb JASMINE study on nipocalimab meets key endpoints in systemic lupus erythematosus, supporting plans to advance ...

Data presented at ASH 2025 suggest earlier-line use of cilta-cel leads to better outcomes in multiple myeloma because patients have fitter immune systems and less exhausted T cells, improving CAR T ...

Imaavy will now progress to Phase III in SLE, though it will face strong competition from SLE market leader, Benlysta, if ...

Multiple sclerosis (MS) is a chronic autoimmune disease in which the immune system attacks the body’s nerves. Immune cells ...

This review contains spoilers for Fallout Season 2, Episode 4, “The Demon in the Snow,” which is available to stream now on ...

Enveda, a multi-asset clinical-stage biotech company pioneering the discovery and development of a new generation of ...

“Gedatolisib plus Faslodex, with or without Ibrance, represents a potential new standard of care for patients with hormone ...

Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference Reaching more metastatic uveal melanoma patients ...

But if regulatory measures take hold, clubs and fans might finally glimpse the full cost of the game. Until then, every ...